UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 9 | September 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 5
May-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2305713


Registration ID:
516116

Page Number

h77-h82

Share This Article


Jetir RMS

Title

Outcome of Treatment of Capillary Haemangioma with Intralesional Triamcinolole Acetonide Injection

Abstract

Capillary hemangioma (infantile hemangioma, juvenile hemangioma, or strawberry nevus of infancy) is one of the most common benign orbital tumors of childhood affecting up to 5% of infants under the age of 1 year. It can be superficial, presenting as a red, raised lesion, it can be deep, presenting as a dark blue lesion that may extend into the orbit or may present both of the above components. Capillary hemangiomas involving the eyelids may induce astigmatic anisometropic and amblyopia causing severe vision loss if left untreated. However the present study has conducted to explore results of intralesional Triamcinolone Acetonide injection for the treatment of capillary haemangioma. The study was conducted at Chittagong city in Bangladesh. The study was case study type. For this reason three patients were selected. All of these three babies came to our department with the same complaints that their parents noticed superficial cutaneous lesions, appearing dark blue on purple though the overlying skin around the eyelids till birth. The parents also noticed the lesions are enlarging and changing colour to deep blue during crying and straining. But both pulstein and bruit are absent. All of these consulted with Paediatric surgeons and paediatricians. Oral tablet Propranolol was given. The patients were treated with intralesional Triamcinolone Acetonide Injection. Dose was 2ml total of 40mg/ml at several sites of the lesion. From the result it was noticed regression starts within 3 weeks. The 2nd & 3rd dose were repeated every after One month and took photographs to compare with the previous Prognosis. As the injections were given superficially, no skin depigmentation was seen. After diagnosis, observations and treatment all the three patients were cured.

Key Words

Capillary haemangioma, Outcome, Treatment, Intralesional Triamcinolole Acetonide injection

Cite This Article

"Outcome of Treatment of Capillary Haemangioma with Intralesional Triamcinolole Acetonide Injection", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 5, page no.h77-h82, May-2023, Available :http://www.jetir.org/papers/JETIR2305713.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Outcome of Treatment of Capillary Haemangioma with Intralesional Triamcinolole Acetonide Injection", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 5, page no. pph77-h82, May-2023, Available at : http://www.jetir.org/papers/JETIR2305713.pdf

Publication Details

Published Paper ID: JETIR2305713
Registration ID: 516116
Published In: Volume 10 | Issue 5 | Year May-2023
DOI (Digital Object Identifier):
Page No: h77-h82
Country: Dhaka, Dhaka, Bangladesh .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000228

Print This Page

Current Call For Paper

Jetir RMS